Bill Text: NY A09252 | 2023-2024 | General Assembly | Introduced
Bill Title: Provides standards for correctional facilities in relation to medication assisted treatment for opioid use disorders and the testing for opioid use when an individual is first incarcerated.
Spectrum: Partisan Bill (Republican 5-0)
Status: (Introduced) 2024-05-14 - held for consideration in correction [A09252 Detail]
Download: New_York-2023-A09252-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 9252 IN ASSEMBLY February 22, 2024 ___________ Introduced by M. of A. GRAY -- read once and referred to the Committee on Correction AN ACT to amend the correction law and the mental hygiene law, in relation to providing medication assisted treatment for opioid use disorders to incarcerated individuals in county correctional facili- ties The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 19 of section 45 of the correction law, as 2 amended by chapter 486 of the laws of 2022, is amended to read as 3 follows: 4 19. Establish standards and guidelines for a program of medication 5 assisted treatment for incarcerated individuals in county jails and/or 6 county correctional facilities [equivalent to the program established in7state correctional facilities pursuant to section six hundred twenty-six8of this chapter and submit an annual report consistent with the require-9ments of subdivision three of such section] pursuant to section 19.18-c 10 of the mental hygiene law. 11 § 2. Subdivision 5 of section 505 of the correction law, as added by 12 chapter 147 of the laws of 2022, is amended to read as follows: 13 5. Corrections-based substance use disorder treatment and transition 14 services. Local correctional facilities shall operate a substance use 15 disorder treatment and transition services program pursuant to a plan 16 approved by the commissioner of the office of addiction services and 17 supports in accordance with section 19.18-c of the mental hygiene law 18 and section five hundred six of this article. 19 § 3. The correction law is amended by adding a new section 506 to read 20 as follows: 21 § 506. Medical testing for opioid use. 1. All incarcerated individuals 22 within county correctional facilities will be medically tested for 23 opioid use upon incarceration. 24 2. Such testing shall be done by an organization, agency or medical 25 professional that is separate and independent from the providers of 26 medication assisted treatment. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD13945-01-3A. 9252 2 1 3. Incarcerated individuals who test positive for opioid use shall be 2 informed of their eligibility for medication assisted treatment in 3 accordance with section 19.18-c of the mental hygiene law. 4 § 4. Section 19.18-c of the mental hygiene law, as amended by chapter 5 147 of the laws of 2022, is amended to read as follows: 6 § 19.18-c Corrections-based substance use disorder treatment and transi- 7 tion services. 8 1. Notwithstanding any other provision of this chapter, the commis- 9 sioner, in consultation with local governmental units, county sheriffs, 10 the New York city department of corrections and other stakeholders, 11 shall implement a jail-based substance use disorder treatment and tran- 12 sition services program that supports the initiation, operation and 13 enhancement of substance use disorder treatment and transition services 14 for persons with substance use disorder who are incarcerated in jails. 15 2. The services to be provided by such program shall be in accordance 16 with plans developed by participating local governmental units, in 17 collaboration with county sheriffs, [taking into account local needs and18available resources] medical professionals and correctional administra- 19 tors for the most effective, least costly methods. These plans must be 20 approved by the commissioner and shall include, but not be limited to, 21 the following: 22 (a) Alcohol, benzodiazepine, heroin and opioid withdrawal management; 23 (b) [At least one formulation of every form of] Such formulations of 24 medication assisted treatments approved for the treatment of a substance 25 use disorder by the Federal Food and Drug Administration necessary to 26 ensure that each individual participating in the program receives the 27 particular form found to be the most effective, least costly method at 28 treating and meeting their individual needs while minimizing the diver- 29 sion of medication within the facility. The commissioner may allow 30 jails a limited exemption to providing opioid full agonist treatment 31 medications where the commissioner determines that no providers that 32 have received the required accreditation are located within a reasonable 33 distance of the facility. Jails that do not have the resources avail- 34 able to meet standards set forth herein may apply to the commissioner 35 for a limited exception allowing such jail to enter into an agreement 36 with a community- or jail-based program offering substance use disorder 37 treatment and transition services to provide such services to individ- 38 uals in such jails. Any such determination shall be reviewed on a regu- 39 lar basis; 40 (c) Group and individual counseling and clinical support; 41 (d) Peer support; 42 (e) Discharge planning; [and] 43 (f) Behavioral therapies; and 44 (g) Re-entry and transitional supports. 45 3. (a) After [a] medical [screening] testing, incarcerated individuals 46 who are determined to suffer from a substance use disorder for which 47 medication assisted treatment exists shall be offered placement in the 48 medication assisted treatment program. Placement in such program shall 49 not be mandatory. 50 (b) Each participating incarcerated individual shall work with an 51 authorized specialist to develop an individualized treatment plan, 52 including an appropriate level of counseling and planning for continuity 53 of care upon return to the community. 54 (c) Decisions regarding type, dosage, or duration of any medication 55 regimen shall be made by a qualified health care professional licensed 56 or certified under title eight of the education law who is authorized toA. 9252 3 1 administer such medication in conjunction with the incarcerated individ- 2 ual and shall be done in consultation with correctional administrators 3 for the most effective, least costly method. 4 (d) Participation in the medication assisted treatment program shall 5 not be unreasonably withheld from a qualified incarcerated individual. 6 An incarcerated individual using medication assisted treatment prior to 7 such individual's incarceration shall be eligible to, upon request by 8 such individual[, continue such treatment in the medication assisted9treatment program for any period of time during the duration of such10individual's incarceration] within seventy-two hours of incarceration, 11 receive such treatment and shall continue such treatment for any period 12 of time during the duration of incarceration at the option of such indi- 13 vidual. 14 (e) If not actively in medication assisted treatment throughout incar- 15 ceration, the individual may, within four weeks prior to such incarcer- 16 ated individual's scheduled release date, participate in medication 17 assisted treatment, provided such incarcerated individual tested posi- 18 tive for opioid use or was actively participating in a treatment plan 19 prior to incarceration. 20 (f) No person shall be denied participation in the program on the 21 basis of a positive drug screening upon entering custody or upon intake 22 into the program; nor shall any person receive a disciplinary infraction 23 for such positive drug screening. No person shall be removed from, or 24 denied participation in the program on the basis of having received any 25 disciplinary infraction: (1) before entry into the program; or (2) 26 during participation in the program. 27 4. Within amounts appropriated therefor, funding shall be made avail- 28 able pursuant to criteria established by the office of addiction 29 services and supports in consultation with local governmental units, 30 which shall take into consideration the local needs and resources as 31 identified by local governmental units, the average daily jail popu- 32 lation, the average number of persons incarcerated in the jail that 33 require substance use disorder services and such other factors as may be 34 deemed necessary. 35 5. The office of addiction services and supports shall develop and 36 implement a training program for correctional staff and healthcare 37 providers necessary for the implementation of medication assisted treat- 38 ment. 39 6. Any jail-based substance use disorder treatment and transition 40 services program that is already in operation at the time this act shall 41 have become law and meets or exceeds the standards set forth in this 42 section shall be deemed to have met the requirements of subdivisions one 43 and two of this section. Such programs shall certify annually in writing 44 to the commissioner that they have met or exceeded the standards set 45 forth herein. 46 § 5. This act shall take effect on the ninetieth day after it shall 47 have become a law. Effectively immediately, the addition, amendment 48 and/or repeal of any rule or regulation necessary for the implementation 49 of this act on its effective date are authorized to be made and 50 completed on or before such date.